Literature DB >> 4634493

Inhibitory effect of L-Dopa on GH release in acromegalic patients.

A Liuzzi, P G Chiodini, L Botalla, G Cremascoli, F Silvestrini.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4634493     DOI: 10.1210/jcem-35-6-941

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  24 in total

Review 1.  A history of acromegaly.

Authors:  R Sheaves
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

2.  Treatment of pituitary tumors: history.

Authors:  Gaya Thanabalasingham; Niki Karavitaki; Simon Cudlip; John A H Wass
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

Review 3.  Bromocriptine in the treatment of acromegaly.

Authors:  D E Bateman; W M Tunbridge
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

4.  Effect of vitamin B6 on the serum concentration of pituitary hormones in normal humans and under pathologic conditions.

Authors:  M Bigazzi; S Ferraro; R Ronga; G Scarselli; V Bruni; A L Olivotti
Journal:  J Endocrinol Invest       Date:  1979 Apr-Jun       Impact factor: 4.256

Review 5.  Medical treatment of pituitary adenomas: effects on tumor growth.

Authors:  A Liuzzi; P G Chiodini; D Dallabonzana; G Oppizzi; G G Verde
Journal:  J Endocrinol Invest       Date:  1985-06       Impact factor: 4.256

6.  Bromocriptine treatment of acromegaly.

Authors:  M O Thorner; A Chait; M Aitken; G Benker; S R Bloom; C H Mortimer; P Sanders; A S Mason; G M Besser
Journal:  Br Med J       Date:  1975-02-08

7.  Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.

Authors:  S A Fine; L A Frohman
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

8.  Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.

Authors:  M Ishibashi; T Yamaji
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

9.  Macroprolactinomas: CT evaluation of reduction of tumor size after medical treatment.

Authors:  G Scotti; G Scialfa; S Pieralli; P G Chiodini; B Spelta; D Dallabonzana
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

10.  Increased glucose turnover and glucose cycling in acromegalic patients with normal glucose tolerance.

Authors:  S Karlander; M Vranić; S Efendić
Journal:  Diabetologia       Date:  1986-11       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.